Browsing by Author "Jackson, Christopher"
Now showing 1 - 1 of 1
- Results Per Page
- Sort Options
Item Phase II study of the dual EGFR/HER3 inhibitor duligotuzumab (MEHD7945A) vs. cetuximab in combination with FOLFIRI in RAS wild-type metastatic colorectal cancer(2018-05) Hill, Andrew Graham; Findlay, Michael; Burge, Matthew; Jackson, Christopher; Garcia Alfonso, Pilar; Samuel, Leslie; Ganju, Vinod; Karthaus, Meinolf; Amatu, Alessio; Jeffrey, Mark; Di Bartolomeo, Maria; Bridgewater, John; Coveler, Andrew; Hidalgo, Manuel; Kapp, Amy; Sufan, Roxanna; McCall, Bruce; Hanley, William; Penuel, Elicia; Pirzkall, Andrea; Tabernero, Josep; University of Aberdeen.Aberdeen Centre for Evaluation